The CIS (Commonwealth of Independent States) and Central Eastern Europe injection lipolysis topical products market is a dynamic sector within the beauty and aesthetics industry. It encompasses the distribution and consumption of topical products designed for injection lipolysis; a non-surgical cosmetic procedure used for localized fat reduction. This market involves a wide range of products, such as fat-dissolving solutions and related equipment. Evolving beauty standards and a growing interest in non-invasive treatments influence the region's demand for such products.
Access Full Report at https://www.databridgemarketresearch.com/zh/reports/cis-and-central-eastern-europe-injection-lipolysis-topical-products-market
Data Bridge Market Research analyses that the CIS and Central Eastern Injection Lipolysis Topical Products Market is growing with a CAGR of 9.2% in the forecast period of 2022 to 2029 and is expected to reach USD 19,733.67 thousand by 2029 from USD 10,035.05 thousand in 2021. The aging population's desire for youthful appearances fuels the demand for injection lipolysis products. As people age, they often experience skin elasticity and fat distribution changes, leading to the desire for non-invasive cosmetic procedures.
Key Findings of the Study
Increasing beauty consciousness is expected to drive the market's growth rate
The rising emphasis on aesthetics and personal appearance is a powerful force propelling the demand for non-invasive cosmetic treatments such as injection lipolysis. In today's image-conscious society, individuals increasingly seek ways to enhance their physical appearance without invasive surgeries. Lipolysis offers an attractive solution by effectively reducing localized fat deposits, thus helping people achieve their desired aesthetic goals. This cultural shift towards valuing beauty and self-confidence has fostered a surge in the popularity of these non-surgical procedures, driving the growth of the cosmetic industry.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Thousand, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Area of Application (Abdominal Fat, Thighs Fat, Upper Arm Fat, Facial Fat Deposits, Buttock Fat, Knee Fat, Others), Gender (Female, Male), End User (Ambulatory Surgical Centers (ASCS), Clinics, Hospitals, Others), Distribution Channel (Direct Tender, Retail Sales, Others).
|
|
Countries Covered
|
Germany,U.K., France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Slovenia, Liechtenstein, Rest of Central Europe, Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia, Rest of CIS Countries.
|
|
Market Players Covered
|
AbbVie (U.S.), Leaderma Inc. (South Korea), Marllor Biomedical Srl (Italy), Mesosystem (Spain), Laboratorio Innoaesthetics, S.L. (Spain) and others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The CIS and Central Eastern Europe injection lipolysis topical products market is segmented on the basis of area of application, gender, end user, and distribution channel.
- On the basis of area of application, the CIS and Central Eastern Europe injection lipolysis topical products market is segmented into abdominal fat, thighs fat, upper arm fat, facial fat deposits, buttock fat, knee fat, others
- On the basis of Gender, the CIS and Central Eastern injection lipolysis topical products market is segmented into female, and male
- On the basis of end user, the CIS and Central Eastern Europe injection lipolysis topical products market is segmented into ambulatory surgical centers (ASCS), clinics, hospitals, and others
- On the basis of distribution channel, the CIS and Central Eastern Europe injection lipolysis topical products market is segmented into direct tender, retail sales, and others
Major Players
Data Bridge Market Research recognizes the following companies as the major CIS and Central Eastern Europe injection lipolysis topical products market players in CIS and Central Eastern Europe injection lipolysis topical products market are AbbVie (U.S.), Leaderma Inc. (South Korea), Marllor Biomedical Srl (Italy), Mesosystem (Spain), Laboratorio Innoaesthetics, S.L. (Spain).
Market Developments
- In September 2021, AbbVie, a global pharmaceutical leader, disclosed their acquisition of Leaderma Inc., a South Korean company specializing in injection lipolysis products. This strategic move enhances AbbVie's presence in the CIS and Central Eastern Europe market, offering the region a broader portfolio of aesthetic solutions
- In July 2021, Leaderma Inc. disclosed a strategic collaboration with Marllor Biomedical Srl to expand their presence in the CIS and Central Eastern Europe market. This collaboration will leverage Leaderma's innovative topical products with Marllor's regional expertise, fostering enhanced market penetration and growth prospects
- In April 2021, AbbVie Inc. expanded its medical aesthetics product portfolio by introducing SkinMedica Neck Correct Cream. This innovative cream, clinically proven to firm and rejuvenate crepey skin, reduces sagging, smooths lines and wrinkles, and improves skin tone, enhancing the company's offerings in non-invasive cosmetic treatments
Regional Analysis
Geographically, the countries covered in the CIS and Central Eastern Europe injection lipolysis topical products market report are Germany, U.K., France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Slovenia, Liechtenstein, Rest of Central Europe, Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia, Rest of CIS Countries.
As per Data Bridge Market Research analysis:
Germany is the dominant region in the CIS and Central Eastern Europe injection lipolysis topical products market during the forecast period 2022-2029
Germany's dominance in fat reduction procedures is attributed to advanced technology and the widespread adoption of minimally invasive techniques. The country's commitment to innovation ensures cutting-edge procedures, making it a leader in the field. This technological prowess and a preference for less invasive methods position Germany at the forefront of the global fat reduction market.
For more detailed information about the CIS and Central Eastern Europe injection lipolysis topical products market report, click here – https://www.databridgemarketresearch.com/zh/reports/cis-and-central-eastern-europe-injection-lipolysis-topical-products-market
